Enrico Cerrato to Aged
This is a "connection" page, showing publications Enrico Cerrato has written about Aged.
Connection Strength
0.162
-
Left Ventricular Free-Wall Rupture. N Engl J Med. 2017 Sep 07; 377(10):e13.
Score: 0.013
-
Characteristics, in-hospital management and outcome of late acute ST-elevation myocardial infarction presenters. J Cardiovasc Med (Hagerstown). 2017 Aug; 18(8):567-571.
Score: 0.013
-
Combined intracoronary 2D-3D optical coherence tomography and intravascular ultrasound imaging in left main severe stent malapposition. Cardiovasc Interv Ther. 2018 Jul; 33(3):288-290.
Score: 0.013
-
COVID-19 and the impact of arterial hypertension-An analysis of the international HOPE COVID-19 Registry (Italy-Spain-Germany). Eur J Clin Invest. 2021 Nov; 51(11):e13582.
Score: 0.004
-
Gender Differences in the Presentation and Outcomes of Hospitalized Patients With COVID-19. J Hosp Med. 2021 06; 16(6):349-352.
Score: 0.004
-
Non-invasive ventilation for SARS-CoV-2 acute respiratory failure: a subanalysis from the HOPE COVID-19 registry. Emerg Med J. 2021 May; 38(5):359-365.
Score: 0.004
-
COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry. Infection. 2021 Aug; 49(4):677-684.
Score: 0.004
-
Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19. Age Ageing. 2021 02 26; 50(2):326-334.
Score: 0.004
-
Clinical presentation, therapeutic approach, and outcome of young patients admitted for COVID-19, with respect to the elderly counterpart. Clin Exp Med. 2021 May; 21(2):249-268.
Score: 0.004
-
Underlying heart diseases and acute COVID-19 outcomes. Cardiol J. 2021; 28(2):202-214.
Score: 0.004
-
Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis. Front Endocrinol (Lausanne). 2020; 11:599255.
Score: 0.004
-
Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry. Intern Emerg Med. 2021 06; 16(4):957-966.
Score: 0.004
-
Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry. J Nephrol. 2020 08; 33(4):737-745.
Score: 0.004
-
Prognostic Value of QFR Measured Immediately After Successful Stent Implantation: The International Multicenter Prospective HAWKEYE Study. JACC Cardiovasc Interv. 2019 10 28; 12(20):2079-2088.
Score: 0.004
-
Daily risk of adverse outcomes in patients undergoing complex lesions revascularization: A subgroup analysis from the RAIN-CARDIOGROUP VII study (veRy thin stents for patients with left mAIn or bifurcatioN in real life). Int J Cardiol. 2019 09 01; 290:64-69.
Score: 0.004
-
Management of aspirin intolerance in patients undergoing percutaneous coronary intervention. The role of mono-antiplatelet therapy: a retrospective, multicenter, study. Minerva Cardioangiol. 2019 Apr; 67(2):94-101.
Score: 0.004
-
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry. Eur J Prev Cardiol. 2020 05; 27(7):696-705.
Score: 0.004
-
Radial and femoral access for interventional fellows performing diagnostic coronary angiographies: the LEARN-Cardiogroup II, a prospective multicenter study. J Cardiovasc Med (Hagerstown). 2018 Nov; 19(11):650-654.
Score: 0.004
-
Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMI. Eur Heart J Acute Cardiovasc Care. 2019 Sep; 8(6):536-542.
Score: 0.004
-
Acute and long-term outcomes after polytetrafluoroethylene or pericardium covered stenting for grade 3 coronary artery perforations: Insights from G3-CAP registry. Catheter Cardiovasc Interv. 2018 12 01; 92(7):1247-1255.
Score: 0.004
-
Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registry. Int J Cardiol. 2018 Dec 15; 273:29-33.
Score: 0.003
-
Long-Term Outcomes of Different Two-Stent Techniques With Second-Generation Drug-Eluting Stents for Unprotected Left Main Bifurcation Disease: Insights From the FAILS-2 Study. J Invasive Cardiol. 2018 08; 30(8):276-281.
Score: 0.003
-
State of Transcatheter Aortic Valve Implantation in Spain Versus Europe and Non-European Countries. J Invasive Cardiol. 2018 08; 30(8):301-309.
Score: 0.003
-
Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome. Rev Esp Cardiol (Engl Ed). 2019 Mar; 72(3):215-223.
Score: 0.003
-
Safety of FFR-guided revascularisation deferral in Anatomically prognostiC diseasE (FACE: CARDIOGROUP V STUDY): A prospective multicentre study. Int J Cardiol. 2018 Nov 01; 270:107-112.
Score: 0.003
-
Unprotected Left Main Coronary Artery Disease: Outcomes of Treatment With Second-Generation Drug-Eluting Stents - Insight From the FAILS-2 Study. J Invasive Cardiol. 2018 08; 30(8):283-288.
Score: 0.003
-
The EUROpean and Chinese cardiac and renal Remote Ischemic Preconditioning Study (EURO-CRIPS CardioGroup I): A randomized controlled trial. Int J Cardiol. 2018 04 15; 257:1-6.
Score: 0.003
-
The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery Disease. JACC Cardiovasc Interv. 2017 12 11; 10(23):2401-2410.
Score: 0.003
-
Antiplatelet Monotherapy After Percutaneous Coronary Intervention. Contemporary Long-term Outcomes and Matched Comparison With Routine Clinical Practice. Rev Esp Cardiol (Engl Ed). 2018 Nov; 71(11):984-986.
Score: 0.003
-
Influence of the amount of myocardium subtended to a coronary stenosis on the index of microcirculatory resistance. Implications for the invasive assessment of microcirculatory function in ischaemic heart disease. EuroIntervention. 2017 10 20; 13(8):944-952.
Score: 0.003
-
Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-study. Int J Cardiol. 2018 Jan 01; 250:80-85.
Score: 0.003
-
Clinical and angiographic outcome of a single center, real world population treated with a dedicated technique of implantation for bioresorbable vascular scaffolds. The FAtebenefratelli Bioresorbable Vascular Scaffold (FABS) registry. J Interv Cardiol. 2017 Oct; 30(5):427-432.
Score: 0.003
-
Optical coherence tomography compared with fractional flow reserve guided approach in acute coronary syndromes: A propensity matched analysis. Int J Cardiol. 2017 Oct 01; 244:54-58.
Score: 0.003
-
Radial Versus Femoral Access for the Treatment of Left Main Lesion in the Era of Second-Generation Drug-Eluting Stents. Am J Cardiol. 2017 07 01; 120(1):33-39.
Score: 0.003
-
Safety and efficacy of drug eluting stents in patients with spontaneous coronary artery dissection. Int J Cardiol. 2017 Jul 01; 238:105-109.
Score: 0.003
-
Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stents-Cardiogroup III Study). Am J Cardiol. 2017 Apr 01; 119(7):978-982.
Score: 0.003
-
Outcome of coronary lesions with deferred revascularization due to negative fractional flow reserve in subjects with acute coronary syndrome. Int J Cardiol. 2017 Mar 01; 230:335-338.
Score: 0.003